Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma
Daruka Mahadevan, Amy Stejskal, Laurence S. Cooke, Ann Manziello, Carla Morales, Daniel O. Persky, Richard I. Fisher, Thomas P. Miller, Wenqing Qi
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma'. Together they form a unique fingerprint.